TrialMedicine2016

High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial.

Ru Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.